Juergen Scheele
7Patents
3h-index
7Co-inventors
42Inventor score
Filing activity: Oct 27, 2011 → Oct 11, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9688760B2 | Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains | Chemistry; Metallurgy | 13 | Active |
| US9192665B2 | Means and methods for treating DLBCL | Chemistry; Metallurgy | 4 | Active |
| US9486475B2 | PPS for the prevention of potential adverse effects caused by CD3 specific binding domains | Human Necessities | 3 | Active |
| US10130638B2 | Prevention of adverse effects caused by CD3 specific binding domains | Chemistry; Metallurgy | 3 | Active |
| US11084876B2 | Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains | Physics | 3 | Active |
| US10696744B2 | Means and methods for treating DLBCL | Chemistry; Metallurgy | 2 | Active |
| US11633408B2 | Prevention of adverse effects caused by CD3 specific binding domains | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.